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Background: RPB1, the largest subunit of RNA polymerase II, contains a highly modifiable C-terminal domain (CTD)
that consists of variations of a consensus heptad repeat sequence (Y1S2P3T4S5P6S7). The consensus CTD repeat motif
and tandem organization represent the ancestral state of eukaryotic RPB1, but across eukaryotes CTDs show
considerable diversity in repeat organization and sequence content. These differences may reflect lineage-specific
CTD functions mediated by protein interactions. Mammalian CTDs contain eight non-consensus repeats with a
lysine in the seventh position (K7). Posttranslational acetylation of these sites was recently shown to be required for
proper polymerase pausing and regulation of two growth factor-regulated genes.
Results: To investigate the origins and function of RPB1 CTD acetylation (acRPB1), we computationally
reconstructed the evolution of the CTD repeat sequence across eukaryotes and analyzed the evolution and
function of genes dysregulated when acRPB1 is disrupted. Modeling the evolutionary dynamics of CTD repeat
count and sequence content across diverse eukaryotes revealed an expansion of the CTD in the ancestors of
Metazoa. The new CTD repeats introduced the potential for acRPB1 due to the appearance of distal repeats with
lysine at position seven. This was followed by a further increase in the number of lysine-containing repeats in
developmentally complex clades like Deuterostomia. Mouse genes enriched for acRPB1 occupancy at their
promoters and genes with significant expression changes when acRPB1 is disrupted are enriched for several
functions, such as growth factor response, gene regulation, cellular adhesion, and vascular development. Genes
occupied and regulated by acRPB1 show significant enrichment for evolutionary origins in the early history of
eukaryotes through early vertebrates.
Conclusions: Our combined functional and evolutionary analyses show that RPB1 CTD acetylation was possible in
the early history of animals, and that the K7 content of the CTD expanded in specific developmentally complex
metazoan lineages. The functional analysis of genes regulated by acRPB1 highlight functions involved in the
origin of and diversification of complex Metazoa. This suggests that acRPB1 may have played a role in the success
of animals.
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Eukaryotic RNA polymerases evolved from a single
ancestral enzyme into three structurally related RNA
polymerase enzymes (I–III) with specialized functions in
eukaryotes. RNA polymerase II generates all protein-
coding mRNAs as well as a large number of non-coding
microRNAs (miRNAs), small nuclear RNAs (snRNAs)
and small nucleolar RNAs (snoRNAs). The enzyme is
composed of 12 subunits (RPB1–12), five of which are
shared among the three eukaryotic polymerase com-
plexes. The largest subunit, called RPB1, is unique to
RNA polymerase II and is involved in its catalytic
activity.
The C-terminal domain (CTD) of RPB1 is essential for
the proper regulation of RNA polymerase II [1]. The
CTD consists of a largely unstructured, repetitive stretch
of tandem heptad amino acid repeats with a consensus
sequence of tyrosine-serine-proline-threonine-serine-
proline-serine (Y1S2P3T4S5P6S7). The CTD is connected
to the core polymerase enzyme via a flexible linker close
to the RNA exit site [2] and contains a protein-protein
interaction surface for cofactors involved in the regula-
tion of transcription initiation, elongation and RNA pro-
cessing—highly specialized functions that determine the
speed and reliability of the polymerase enzyme traversing
a gene during transcription [3,4].
In mammals, the CTD heptad repeats undergo a se-
quence of characteristic posttranslational modifications
during transcription [5] and these modifications deter-
mine which cofactors can bind [6]. Phosphorylation of
the S5 residue occurs when the polymerase binds to
gene promoters, and transcription is initiated [7]. The
phospho-S2 modification is a hallmark of elongating
polymerase complexes and is maintained until transcrip-
tion termination occurs [8]. Phosphorylation of S7 resi-
dues in linker-proximal heptad repeats is important for
the transcription of snRNAs and facilitates the interaction
of the RNA polymerase II complex with the Integrator
complex at these genes [9,10]. Methylation of a single
arginine residue plays a role in the production of snoR-
NAs as well as snRNAs and serves as a binding site for
the tudor domain–containing protein TDRD3 [11]. Phos-
phorylation of T4 residues was shown to play a novel
function in 3′-end processing of histone pre-mRNAs [12].
Phosphorylation of Y1 was coupled to antitermination of
transcription [13], and was recently associated with pro-
moters, enhancers, and degradation of RNA polymerase II
[14,15]. However, in spite of our increasing knowledge of
these marks, the full number and identity of repeats that
undergo modification during transcription are unknown.
The CTD repeat motif and tandem repeat orientation
are observed in most eukaryotic model organisms, and
this configuration evolved early in the history of eukary-
otes [16]. However, there is considerable diversity in thenumber and sequence of the repeats across eukaryotic
clades, and the complexity of the CTD is roughly corre-
lated with developmental complexity in animal, plant,
and fungal multicellular lineages [16]. It has been pro-
posed that this diversity in CTD sequences reflects func-
tional constraint due to lineage-specific CTD–protein
interactions [17]. In mammals, non-consensus repeats
are required for the stability of the CTD [18]. How-
ever, deletion of most of the non-consensus repeats
does not affect the housekeeping functions of mam-
malian cells, but it does impair activator-induced gene
transcription [18,19].
A novel CTD modification of non-consensus repeats
necessary for the proper regulation of polymerase paus-
ing was recently discovered [20]. Lysine residues at the
seventh position (K7) in non-consensus distal RPB1
CTD repeats are acetylated (acRPB1) in mouse and hu-
man, but not in yeast (Saccharomyces cerevisiae), where
the repeats lack lysines. This modification, performed by
the acetyltransferase (KAT) enzyme p300/KAT3B, which
is absent in yeast, distinctly marks promoter-proximally
paused polymerases. Disruption of this mechanism inter-
fered with the expression of two growth-factor-induced
genes regulated by polymerase pausing, but did not
influence expression or polymerase occupancy at two
non-paused genes [20].
Knowledge of the evolutionary origins of a gene or
pathway can inform analysis of its functions [21,22].
Thus, we undertook an evolutionary and functional ana-
lysis of the RPB1 CTD sequence and the genes influenced
by acRPB1. We found that the presence of multiple K7
residues, and thus the potential for RPB1 CTD acetylation,
arose with animal multicellularity during an expansion in
the overall number of CTD repeats in Metazoa. Our
phylogenetic analysis further showed that p300/KAT3B,
the acetyltransferase that modifies the RPB1 CTD, was
present at the appearance K7-containing repeats. We then
performed a genome-wide survey of acRPB1 occupancy
and its influence on gene regulation in mice. Genes with
enrichment for acRPB1 at their promoters and genes dys-
regulated when acRPB1 was disrupted were specifically
enriched for functions in growth-factor signaling, cell
adhesion, vascular development, and cell-cell interaction.
In addition, the two sets of acRPB1 sensitive genes were
enriched for evolutionary origins in early eukaryotes
through the ancestor of Euteleostomi (bony vertebrates).
Together, our functional and evolutionary results support
a model in which K7-containing CTDs were selected for
in the early history of animal multicellularity. Given the
association between polymerase pausing and acRPB1, the
potential to acetylate these residues may have enabled
tighter control of gene expression as animals grew in
complexity and diversified. Indeed, acRPB1 now influ-
ences the regulation of growth factor-target genes and
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adhesion and vasculature development, in mammals.
Results
The RPB1 CTD experienced an expansion in repeat
number and lysine content in the early history of animals
The RPB1 CTD has undergone considerable change
during the evolution of eukaryotes [16]. While the con-
sensus repeat sequence Y1S2P3T4S5P6S7 is conserved
from yeast to mammals, the number of repeats varies: S.
cerevisiae has only 26 repeats, while humans have 52
(Figure 1). Conserved heptad repeats are found in the
linker-proximal part of the mammalian CTD, but the se-
quence of the distal heptad repeats, which are not present
in yeast, diverge from this consensus sequence. Eight of
the non-consensus repeats in human and mouse CTDs
carry a lysine at position 7 (K7), rather than serine.
To gain insight into the origins of mammalian K7-con-
taining repeats, we modeled the evolutionary dynamics
of CTD repeats in a phylogenetically diverse collection
of eukaryotes with sequenced RPB1 genes (Figure 2).
Human, mouse, and zebrafish were selected as represen-
tative vertebrate species, based on their phylogenetic
placement and sequence data quality. In addition to the
three vertebrates, we also examined CTD amino acid
sequences for 35 other eukaryotes, including worms, in-
sects, fungi, plants, algae, and several recently sequenced
early branching animals. For each species, we counted
the number of CTD repeats overall, the number of con-
sensus repeats, and the number of repeats with lysine
residues (Figure 2; Additional file 1).
Ancestral state reconstruction using symmetric Wagner
parsimony on the species phylogeny revealed an expan-
sion of CTD repeats in the common ancestor of all Meta-
zoa (Figure 2), as expected from previous studies [16,17].
We estimate that the ancestor of all Metazoa had 44
repeats, while the last common ancestor of Metazoa and
their closest relatives, the choanoflagellates, had only 31
repeats. K7-containing repeats also first appeared consist-
ently in the ancestor of Metazoa, and this was followed by
an increase in the number of K7-containing repeats (from
3 to 7) in the last common ancestor of Deuterosomia.
All the Cnidaria and Ecdysozoa examined have K7-
containing repeats, but with the exception of the deer





Figure 1 The human RNA polymerase II subunit 1 (RPB1) C-terminal
and eight of its non-consensus distal repeats have a lysine residue. I
consensus heptad repeats (YSPTSPS) are colored dark gray; repeats with a
repeats are in white.the number is comparatively small (see Discussion). The
plants, algae, and other eukaryotes we examined have half
as many or fewer repeats as the Metazoa, and only one
has more than two lysine-containing repeats: Plasmodium
falciparum, a human pathogen. (See the Discussion and
[23] for more on the evolution of the Plasmodium falcip-
arum CTD.) Thus, we conclude that CTD repeat length
markedly increased with the origin of animals, and the
distal repeats gained lysine residues and expanded further
in different animal lineages. These results are in agree-
ment with an extensive study of CTD repeat number and
content that appeared while this manuscript was in prep-
aration [16].
We found variations on the consensus CTD heptad re-
peat in all clades (Figure 3). Overall, the seventh position
of the heptad repeat is the most variable, but different
clades exhibit different patterns of variation. Lysines are
common in the seventh position among the deutero-
stomes, and the repeat profiles for individual deutero-
stome species (excepting Brachiostoma floridae) are
more similar to one another than for any other clade.
They average only 3% difference between species. In
Ecdysozoa, positions four, five, and six are more variable
than in other clades, with serines and alanines common
in position four. Fungal CTD repeats, with the exception
of those in Aspergillus oryzae (Figure 3), largely exhibit
the consensus sequence; however, they have more vari-
ation in the first position than other clades. We also
note that some species have a small amount of add-
itional non-repetitive sequence beyond the CTD repeats.
CTD repeat counts and sequences for all species exam-
ined are given in Additional files 1 and 2, respectively.
The acetyltransferase p300 was present for the metazoan
increase in CTD repeat count and lysine content
The p300/KAT3B acetyltransferase was shown to effi-
ciently target and acetylate the mammalian RPB1 CTD,
while another KAT enzyme, PCAF/KAT2B, did not [20].
Recent analysis of the Capsaspora owczarzaki genome
revealed that p300/KAT3B and its paralog, CBP/KAT3A,
were present before the divergence of Capsaspora from
choanoflagellates and metazoans [24]. To further refine
this estimate, we searched for homologs in the additional
early branching holozoan species considered in our










domain (CTD) contains more heptad repeats than the yeasts,
n this schematic of the RPB1 CTD for two species of yeast and human,
lysine at position 7 are colored red; and all other non-consensus
Acanthamoeba castellanii 15 1
Arabidopsis thaliana 37 1
Schizosaccharomyces pombe 29 0
Amphimedon queenslandica 48 3
Mortierella verticillata 30 0
Dictyostelium discoideum 24 0
Mnemiopsis leidyi 52 2
Spizellomyces punctatus 31 0
Mus musculus 52 8
Branchiostoma floridae 43          10
Aspergillus oryzae 22 1
Nematostella vectensis 42 4
Trypanosoma brucei   0 0
Salpingoeca rosetta 31 1
Trichomonas vaginalis   0 0
Sphaeroforma arctica 29 0
Plasmodium falciparum 16          12
Breviata anathema 25 0
Capsaspora owczarzaki 21 0
Culex quinquefasciatus 40 3
Drosophila melanogaster 37 3
Allomyces macrogynus 34 0
Monoblepharis macrandra 10 0
Thecamonas trahens 29 0
Caenorhabditis elegans 37 1
Vairimorpha necatrix 18 0
Ixodes scapularis 49 9
Danio rerio 51 8
Homo sapiens 52 8
Strongylocentrotus purpuratus 44 7
Glaucosphaera vacuolata 20 0
Nosema ceranae 24 2
Saccharomyces cerevisiae 26 0
Monosiga brevicollis 32 0
Leishmania donovani   0 0
Trichoplax adhaerens 27 1
Hydra magnipapillata 58 8












































Figure 2 Lysine-containing CTD repeats first appeared in Metazoa and increased in prevalence in the ancestor of Deuterostomia.
Phylogenetic tree of eukaryotic species considered in our analysis organized by approximate divergence estimates. For each species, the number
of RPB1 CTD repeats and lysine-containing repeats are given. Ancestral counts were inferred for each internal node of the tree using symmetric
Wagner parsimony. The number of CTD heptad repeats increased substantially in the ancestor of all Metazoa (31 to 44 repeats). This was
accompanied by the appearance of repeats with lysine at position seven (K7) in ancestral Metazoa and an increase in K7 repeats in Deuterostomia
(from 3 to 7 repeats).
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(all have BLAST E-values < 7E-155) to human/mouse
p300 and CBP; thus, the ancestor of this gene was
present for the metazoan expansion of the CTD and intro-
duction of K7-containing repeats. Homologs of this family
are present in plants [25], but we did not find clear homo-
logs in the fungi. This suggests that the KAT3 family may
be a more ancient eukaryotic family that has been lost in
some lineages and maintained in others.We also determined the phylogenetic age of 17 KAT
enzymes with expressed in both mouse and humans [26]
using ProteinHistorian [22], a web server that estimates
protein ages, and found a wide range of predicted evolu-
tionary ages (Additional file 3).
Acetylation of RPB1 regulates many mammalian genes
Mutating the RPB1 CTD to prevent acetylation was
shown to disrupt the expression of two immediate-early
Figure 3 Sequence logos summarizing repeat sequence
variation in Fungi, Ecdysozoa, and Deuterostomia. Sequence
logos were generated from all heptad repeat sequences of relevant
species using the LogOddsLogo tool [41]. Most repeat positions are
strongly conserved, but different clades exhibit different variations.
Lysine is particularly common at position seven in Deuterostomia.
See Additional file 1 for RPB1 sequences for all species examined.
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(EGF) and ERK/MAPK pathways with paused polymer-
ases, but it did not influence the expression of several
housekeeping genes [20]. To explore the functional rele-
vance of acetylation of the RPB1 CTD genome-wide, we
analyzed two sets of genes influenced, directly and indir-
ectly, by acRPB1. First, we analyzed the total and acetylated
RNA Pol II promoter occupancy in mouse embryonic
stem cell (ESC) ChIP-Seq data from Schroeder et al. [20].
We found 10,078 genes with acetylated RNA Pol II occu-
pancy at their promoters, and 707 genes with significant
enrichment for acetylated RNA Pol II at their promoters
over total RNA Pol II levels (Methods; Additional file 4).
We will refer to these gene sets as “acRPB1 occupied” and
“acRPB1 enriched,” respectively. Second, we expressed a
mutated murine HA-tagged RPB1 in which all K7 residues
were substituted by arginines (8KR) in mouse NIH/3 T3
fibroblasts (Methods; [20]). This mutation prevents ace-
tylation while preserving the positive charge at these
positions. Gene expression profiling using microarrays
identified 1787 RNAs that were significantly (False Discov-
ery Rate (FDR) < 0.05) up- or down-regulated in 8KR cells
compared to wild type cells. We refer to these as “acRPB1
dysregulated genes”. In the following, we focus on the
acRPB1 enriched genes, which reflect the direct influence
of acRPB1, and the acRPB1 dysregulated genes, which
summarize the broader downstream effects of RPB1
acetylation.
There was significant overlap between the acRPB1
enriched and dysregulated genes (83 genes; p < 0.0001,
chi-squared test). The relatively modest magnitude of
this overlap likely reflects the different origins of the
gene sets. The ChIP-Seq was performed on ESCs, while
the microarrays are from fibroblasts. AcRPB1 is likely in-
volved in many context-dependent responses in different
cells, and a gene with enrichment for acRPB1 at its pro-
moter in one context is not necessarily dysregulated in
all contexts if the ability to acetylate RPB1 is lost. It also
suggests that some genes dysregulated in the disruption
of acRPB1 may not be directly regulated by acRPB1.
However, it is also possible that some differences in the
gene sets result from technical artifacts due to the differ-
ent experimental techniques used to define them.
Genes influenced by acetylation of RPB1 are enriched for
functions in growth-factor response, cell adhesion,
regulation of gene expression, and vasculature development
We used DAVID [27,28] to calculate Gene Ontology
Biological Process (GO BP) annotations and KEGG
pathways enriched among acRPB1 enriched (Table 1)
and dysregulated genes (Table 2). To account for the
many annotations tested, we considered tests with ex-
pected FDR < 0.05 significant. The acRPB1 enriched genes
are annotated with general regulatory GO BP functions
Table 1 Functional annotations and pathways enriched among acRPB1 enriched genes
Functional Annotation Number of genes Fold enrichment Raw p-value FDR
Protein amino acid phosphorylation (GO BP) 42 2.1 7.09E-06 0.01
Neg. regulation of gene expression (GO BP) 34 2.2 1.15E-05 0.02
Neg. regulation of macromol. biosynthetic process (GO BP) 34 2.1 2.89E-05 0.05
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amino acid phosphorylation (FDR = 0.01) and negative
regulation of gene expression (FDR = 0.02) are both sig-
nificantly enriched. The dysregulated genes are enriched
in GO BP functions in cell adhesion (FDR = 6.6E-9), vas-
culature development (FDR = 7.3E-4), and blood vessel
development (FDR = 8.3E-4). The top KEGG pathway en-
richments for both gene sets were largely consistent with
the GO BP analysis, though some did not maintain signifi-
cance after FDR-based multiple test correction. Within
KEGG, the acRPB1 enriched genes had nominally signifi-
cant overlap (uncorrected p < 0.05) with genes involved in
several developmental signaling pathways, focal adhe-
sion, and actin cytoskeleton regulation (Additional file 5).
Similarly, the dysregulated genes showed enrichment
for the focal adhesion (FDR = 0.001) and extracellular
matrix receptor interaction (FDR = 0.02) pathways, as
well as weaker associations with pathways involved in
actin cytoskeleton regulation, axon guidance, and several
signaling and metabolic pathways (Table 2; Additional
file 5). Thus, the direct and indirect targets of acRPB1
appear to be involved preferentially in regulation (both
signaling and transcription), cell adhesion, and vasculature
development.
The disruption of acRPB1 was previously shown to
abolish expression of two epidermal growth-factor-
induced genes, c-Fos and Egr2, in mouse fibroblasts [20].
In order to further explore the connection between
EGF-induced genes and RPB1 CTD acetylation, we ana-
lyzed the expression and promoter acRPB1 occupancy of
several curated sets of growth factor responsive genes.
First, we identified 49 mouse homologs of human genes
whose transcription is directly induced by EGF signaling
(Additional file 6) [29]. Overall, EGF-induced genes over-
lap significantly with acRPB1 enriched genes (5 of 48 with
promoter occupancy data, p = 0.001, Yates’ chi-squared
test), as well as the dysregulated genes (10 of 49; p = 0.001).Table 2 Functional annotations and pathways enriched amon
Functional Annotation Number of genes
Cell adhesion (GO BP) 105
Vasculature development (GO BP) 51
Blood vessel development (GO BP) 50
Focal adhesion (KEGG) 42
ECM-receptor interaction (KEGG) 22
Blood vessel morphogenesis (GO BP) 40The association between acRPB1 and EGF became even
stronger when we considered promoter acRPB1 occu-
pancy (regardless of whether it was significantly higher
than total RPB1 occupancy): 73% (35 of 48) of EGF genes
had acRPB1 occupancy (p = 1E-8). Similarly, the number
of EGF genes nominally dysregulated (p < 0.05) was also
significant (19 of 49; p = 0.003).
Given the association between acRPB1 and EGF-
induced genes, we investigated whether acRPB1 regu-
lated genes induced by other growth factors by analyzing
100 genes induced by platelet-derived growth factor
(PDGF; Additional file 6) [30]. There was a similar enrich-
ment for PDGF-induced genes among acRPB1 occupied
(65 of 100; p = 0) and dysregulated (23 of 100; p = 8E-8)
genes, but not among acRPB1 enriched genes (2 of 100;
p = 0.906). Thus, genes induced by both growth factors
are regulated by acetylation of the RPB1 CTD, though
perhaps mostly indirectly in the case of PDGF. Support-
ing this conclusion, EGF-induced genes were more
strongly enriched among acRPB1-enriched genes than
PDGF-induced genes (p = 0.008, Fisher’s exact test), but
both growth factors were similarly represented among
dysregulated genes (p = 0.381). Fifteen genes were present
in both the EGF- and PDGF-induced sets; the above re-
sults were similar when these genes were not considered
in the analysis.
Growth factor-induced genes can be split into two
categories: immediate-early genes (IEGs) and delayed
primary response genes (DPRGs), which are transcribed
after the IEGs, but before secondary response genes
[30]. These two classes are relevant, because their tran-
scription occurs before de novo protein synthesis, and
thus they reflect the direct effects of growth factor sig-
naling versus those further downstream. Regardless of
the growth factor, both IEGs and DPRGs were enriched
among acRPB1-occupied and -dysregulated genes, but
the effect was stronger for IEGs than DPRGs (Fisher’sg acRPB1 dysregulated genes
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targets many IEGs.
Many genes regulated by acetylation of RPB1 originated
early in the evolution of eukaryotes and animals
Evolutionary analysis by ProteinHistorian showed that
acRPB1-enriched genes had a significantly different age
distribution from all genes with occupancy data (Figure 4A,
p ≈ 0, Mann–Whitney U test). The acRPB1-enriched genes
were significantly enriched for origins on the branch from
Opisthokonta to Bilateria (18.3% vs. 11.8%, p < 0.001), the
branch from Chordata to Euteleostomi (19.2% vs. 13.9%,
p < 0.01), and the ancestral eukaryote branch (14.8% vs.
7.7%, p < 0.001). (Note that due to the species present in
the ProteinHistorian database, the resolution of the pro-
tein age analysis is not as high as the CTD repeat analysis.)
Comparing the evolutionary origins of dysregulated
genes to the background of all genes on the array re-
vealed a similar age pattern (Figure 4B; p = 1.4E-52). In
particular, the dysregulated genes were enriched for
origins in the ancestral eukaryote, the early history of
animals (Opisthokonta to Bilateria branch), and shortly
thereafter on the Deuterostomia to Chordata and Chord-
ata to Euteleostomi branches (p < 0.001 for each). Both
gene sets showed consistent depletion of genes born
after the origin of amniotes. Thus, two independent
ways of defining genes influenced by acRPB1 under-
score a potential role for K7 acetylation in regulating
RNA polymerase II function at genes that were present
as animal multicellularity developed and diversified
(Figure 4).Figure 4 Genes regulated by acRPB1 are significantly enriched for ev
ProteinHistorian analysis of the evolutionary origins of acRPB1 enriched gen
background gene sets. Each bar gives the difference between the proporti
common ancestor of a given taxon (* = p < 0.05, ** = p < 0.01, *** = p < 0.00
origins in each taxon is given along the x-axis. For example, 18% of the acRPB
and Bilateria, and this is significantly more (~7%, p < 0.001) than expected fromMany genes involved in functions enriched among the
acRPB1-regulated genes have origins close to the origin
of K7 repeat-containing CTDs or later during the origin
and radiation of vertebrates (Figure 5). The window be-
tween the K7 repeat expansion and the diversification of
vertebrates is enriched with the origin of acRPB1-
regulated genes. For example, the EGF-induced genes
are significantly enriched for origins on the branch leading
to Euteleostomi (p < 0.0001), as are the PDGF-induced
genes (p < 0.0001) (Figure 5). Consistent with this pattern,
twelve of the 17 (71%) genes in the EGF signal transduc-
tion pathway (BIOCARTA), which are necessary for EGF
induction, were born between the origin of Bilateria and
Euteleostomi; three were present in the last common an-
cestor of eukaryotes (e.g., MAPK), and only one appeared
after the Euteleostomi (Additional file 6). Thus, this path-
way’s evolutionary history mirrors that of the genes influ-
enced by acRPB1 (Figure 4).
Discussion
AcRPB1 likely first occurred early in the development of
animals
Our integrated evolutionary and functional analyses of
RPB1, its modifiers, regulators, and targets suggest that
the potential for acRPB1 was present in early animals.
While we cannot definitively establish the timing of the
first acRPB1 event, several lines of evidence suggest that
acRPB1 began to occur soon after K7-containing heptad
repeats appeared during the increase in RPB1 CTD
repeat length in the metazoan ancestor. First, elevated
repeat count and K7-containing repeats are present inolutionary origins from early eukaryotes through early animals.
es (A) and acRPB1 dysregulated genes (B) compared with relevant
on of genes of interest and background genes originating in the last
1, all Bonferroni corrected). The proportion of genes of interest with
1 enriched genes likely appeared between the origin of Opisthokonta
the background of all genes with occupancy data.
Figure 5 Summary of the origins of subsets of genes regulated by acRPB1 with respect to relevant evolutionary events. The period
between K7 repeat expansion and the diversification of vertebrates, shows particular enrichment for the origin of acRPB1 regulated genes and
genes with functions relevant to animals. Each column in the heat map represents the evolutionary origin distribution of a set of genes. Color
intensity reflects the magnitude of increase over background in each evolutionary window. Due to the large difference for some gene sets, two
scales were necessary (red and purple). Asterisks indicate significant increase over background (Bonferroni-corrected p < 0.05). Relevant
evolutionary events are identified with blue triangles. For reference, the first two columns represent the acRPB1 enriched and dysregulated origin
distributions (Figure 4). The remaining columns give the origin distributions for functional subsets of genes enriched among acRPB1
sensitive genes.
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rare outside of Metazoa. Third, the ancestor of the p300
KAT enzyme, which acetylates CTD K7 residues, was
present when the CTD expanded. Fourth, the genes
bound and regulated by acRPB1 are enriched for evolu-
tionary origins before and during the appearance anddiversification of animals and depleted for origins more
recent than the last common ancestor of all bony verte-
brates (Euteleostomi). Finally, the functions enriched
among genes regulated by acRPB1 suggest involvement
in traits essential to the origin and development of com-
plex animal multicellularity.
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regulation of some functions essential to complex
multicellular animals
Transitions to multicellular lifestyles require organisms
to perform a range of new functions that facilitate
cell adhesion, cell-cell signalling, and context-dependent
gene expression [31,32]. We found enrichment for func-
tions in cell adhesion, extracellular matrix signaling, gene
regulation, and phosphorylation among genes influenced
by acRPB1 (Tables 1 and 2). This suggests a connection
between new regulatory mechanisms, such as polymerase
pausing, enabled by acRPB1 and the development of ani-
mal multicellularity. In addition, the enrichment for vas-
cular development among the genes sensitive to acRPB1
supports the involvement of acRPB1 in the later devel-
opment and regulation of animal body plan complexity.
Indeed, intercellular regulation of proliferation, differ-
entiation, and migration by paracrine factors such as
EGF is a unique feature of higher eukaryotes and lies at
the root of body complexity in animals [33]. Our ana-
lyses show that proper regulation of genes induced by
two growth factors, EGF and PDGF, is dependent on the
presence of K7 residues in the CTD. While our study
explicitly provides evidence for the importance of K7
residues in EGF- and PDGF-induced transcription, it
also suggests that other signal transduction pathways in
higher eukaryotes may rely on K7 residues for proper
gene activation.
What is the role of acRPB1 in different animal lineages?
The eukaryotic RPB1 CTD experiences posttranslational
phosphorylation and methylation modifications that are
essential for proper regulation of its activity. The initial
expansion in CTD repeat number during the origin of
Metazoa likely increased the potential for these RPB1
modifications. Our work suggests that acRPB1 appeared
soon after this initial expansion. The integration of K7
residues into the RPB1 heptad repeat appears to predate
the divergence of the Cnidaria, Ecdysozoa, and Deuter-
ostomia; however, these clades exhibit differences in the
number and type of repeats. Deuterostomes exhibit dra-
matic and consistent high K7 count (Figure 2). Nonethe-
less, the presence of at least one K7-containing repeat is
conserved in all species analyzed in these clades, and
some species (H. vulgaris and I. scapularis) have high K7
counts. Given the role of acRPB1 in promoter-proximal
polymerase pausing [20] and the importance of pausing in
non-deuterostome species, such as Drosophila melanoga-
ster [34], it is possible that acRPB1 occurs commonly in
these species in spite of their lower K7 content. Indeed,
a single K7-containing repeat in a modified mouse CTD
was sufficient to produce detectable acetylation in vitro
[20]. Most pausing research has been performed in
human, mouse, or fly, and the full phylogenetic range ofpolymerase pausing is not known. However, it appears
that pausing is rare in Caenorhabditis elegans [35], a
species with only one K7 repeat, but systematic studies
of pausing and acRPB1 in a more diverse array of species
are necessary to resolve this question.
AcRPB1 may be associated with developmental
complexity in different eukaryotic lineages
Recent work has established the plasticity of the RPB1
CTD across eukaryotes and suggested that lineage-
specific CTD modifications are associated with increased
complexity in different multicellular lineages [16]. While
our work does not prove the involvement of acRPB1 in
the development of animal multicellularity, it suggests
that this novel regulatory mechanism may have played a
role in the establishment of the complex gene regulatory
programs necessary for the proper cooperation of different
cells within complex multicellular animals, in addition
to known expansions and rearrangements of gene
families [36].
The presence of a non-consensus K7 repeat in many
plant species [16] suggests the possibility that acRPB1
could have evolved in parallel in another developmen-
tally complex multicellular lineage. However, it is not
known whether plant K7 repeats are acetylated.
Why are many K7-containing repeats seen in some
species of malaria?
K7-containing repeats are rare outside of animals, yet in
agreement with previous studies, we see many K7 re-
peats in P. falciparum, a parasite that causes malaria in
humans (Figure 2). In general, Plasmodium species have
very short repeat regions with high variability between
and within species [16,23]. Primate-infecting Plasmodium
species have many K7 repeats, yet this is not true of those
that infect other mammals, like rodents, and birds. Ana-
lysis of the CTDs of many Plasmodium species suggests
that expansion of K7 repeats in the CTD occurred twice in
parallel in different lineages of primate parasites; however,
the forces driving these independent primate-specific ex-
pansions are not known. The establishment of the acetyl-
ation of the CTD [20] and its importance in regulating
many ancient genes suggests that CTD acetylation may be
involved. However, since acRPB1 occurs in mice, the pres-
ence of K7 repeats and acRPB1 in the host does not neces-
sarily result in high K7 content in the Plasmodium CTD.
Horizontal transfer of epigenetic regulators, like the Set2
and Set8 methyltransferase domains, occurred in the
ancestor of Apicomplexans and has been linked to their
transition to parasitism [37]. The Set2 domain interacts
with the CTD, but it is absent in rodent infecting Plasmo-
dium species. This suggests that there may be differences
in the epigenetic methylation and acetylation of the CTD
in Plasmodium species infecting different mammals, but
Simonti et al. BMC Evolutionary Biology  (2015) 15:35 Page 10 of 12the nature and effects of these modifications remain
uncertain.
Conclusions
In this work, we trace the evolutionary origin of K7-
containing RPB1 CTD repeats to the early history of
animals. Our integrated evolutionary and functional
analyses suggest that the potential for acRPB1 was present
at this time and suggest, due to the conserved increased
CTD repeat count and K7 content, that acRPB1 is a com-
mon regulatory mechanism in many animals. Most studies
of the genetic changes involved in transitions to animal
multicellularity have implicated expansions or rearrange-
ments of gene families [36]. While our work does not
prove the involvement of acRPB1 in this transition, it sug-
gests that this novel regulatory mechanism may have pro-
vided a foundation on which gene regulatory programs
involved in the proper function and cooperation of




We identified species with sequenced RPB1 genes using
BLAST searches and previous studies of RPB1 [38]. We
confirmed that all sequenced vertebrates have the same
pattern of repeats as human and selected human, mouse,
and zebrafish (Danio rerio) as representative vertebrate
species, based on their phylogenetic placement and
sequence data quality. Removal of other vertebrate se-
quences avoids problems with oversampling, as well
as problems associated with poor quality or missing
data in some species. In addition to the three verte-
brates, we included RPB1 amino acid sequences for
35 other eukaryotes, including worms, insects, plants,
algae, amoebas, fungi, and several recently sequenced,
early branching animals. For each species’ RPB1 sequence,
we manually counted the number of CTD heptad repeats
and the number of CTD repeats with lysine residues
(Additional file 1). To be classified as an acceptable hep-
tad, three of the seven amino acids had to match the con-
sensus sequence or common alterations seen in multiple
species.
We modified a species tree downloaded from the
NCBI Taxonomy Database to reflect recent research on
the evolutionary relationships between the clades con-
sidered and the approximate timing of divergence events
[36,39]. To model losses and gains of CTD repeats and
lysine content within each ancestral clade, we used
Wagner parsimony (with an equal weight for gains and
losses) as implemented in the Count program for analysis
of numerical observations on a phylogeny [40].
Estimates of the phylogenetic age of human and mouse
genes were made with ProteinHistorian using asymmetricWagner parsimony on the PPOD-PANTHER protein-
family database [22]. ProteinHistorian was also used to
identify significant differences in the distribution of gene
ages between gene sets of interest, such as those occupied
by different polymerase forms or in different functional
classes.
Sequence logo generation
Sequence logos for clades were created using the online
tool LogOddsLogo [41]. In generation of the summary
logos for clades, all heptad repeats from the specified spe-
cies were input into the generator.
Identification of acRPB1 occupied and enriched genes
To determine promoter RPB1 occupancy genome-wide,
we used ChIP-Seq data collected with antibodies for
total RPB1 and acetylated RPB1 in mouse embryonic
stem cells from [20]. Following their definitions, we con-
sidered a gene to be “RPB1 occupied” if it had total
RPB1 signal at its promoter (2 kilobases upstream of the
transcription start site) greater than twice the input
signal at the promoter (total/input > 2). Similarly, we de-
fined “acRPB1 occupied” genes as those with acRPB1
occupancy twice that of the promoter input signal
(ac/input > 2). Since the amount of acRPB1 at a pro-
moter strongly correlated with the amount of RPB1
[20], we defined a set of “acRPB1 enriched” genes that
were RPB1 occupied and had acRPB1 promoter occu-
pancy at least twice the RPB1 occupancy (total/input > 2
and ac/total > 2). The genes in each set are listed in
Additional file 4.
Identification of genes dysregulated with the disruption
acRPB1
We used a HA-tagged mouse RPB1 construct in which
all K7 residues were substituted with arginines (8KR)
[20]. This mutation resembles unacetylated lysines by
conserving the positive charge at these positions, but
preventing acetylation. To examine the potential func-
tions of K7 acetylation in regulating gene expression, we
stably expressed wildtype or 8KR HA-RPB1 in murine
NIH/3 T3 fibroblasts and cultured these cells in media
containing α-amanitin. Both were expressed at equiva-
lent levels, but acetylation was present only in wildtype,
and not mutant HA-RPB1. We then performed gene
expression profiling using the Affymetrix Mouse Gene
1.0 ST microarray with three biological replicates. Array
values were normalized and log2 scaled. For statistical
analyses, we removed all array probe sets in which
no experimental groups had an average log2 intensity
greater than 3.0. This is a standard cutoff, below which
expression is indistinguishable from background noise.
Linear models were fit for each gene with the Bioconduc-
tor “limma” package in R [42,43]. Moderated t-statistics,
Simonti et al. BMC Evolutionary Biology  (2015) 15:35 Page 11 of 12fold-change and the associated p-values were calculated
for each gene. To account for the fact that thousands of
genes were tested, we controlled the false discovery rate
(FDR) using the Benjamini-Hochberg method [44]. Genes
with p-values corresponding to expected FDRs of 0.05
or less were considered dysregulated compared to wild-
type. These genes are listed in Additional file 4. The raw
array data are available in the Gene Expression Omnibus
(GSE66088).Functional annotation of genes
We used the online functional annotation tool DAVID
[27,28] to calculate KEGG pathway and gene ontology
functional annotation enrichment for each set of genes
of interest. EGF-induced and PDGF-induced genes were
taken from [29] and [30]. The human gene identifiers
from these studies were mapped to their mouse homo-
logs using the HGND database.Availability of supporting data
The data sets supporting the results of this article are
available as additional files. The microarray data we col-
lected are available from the Gene Expression Omnibus
(accession number GSE66088), and the previously col-
lected ChIP-Seq data [20] are available from the Sequence
Read Archive (accession number SRX338012).Additional files
Additional file 1: RPB1 CTD repeat counts for all species considered.
Additional file 2: RPB1 CTD sequences for all species considered.
Additional file 3: Taxa of origin for human/mouse acetyltransferase
genes as predicted by ProteinHistorian.
Additional file 4: Lists of acRPB1 occupied, acRPB1 enriched, and
dysregulated genes.
Additional file 5: GO Biological Process and KEGG pathway
enrichment among acRBP1-enriched and dysregulated genes.
Additional file 6: Lists of EGF and PDGF genes.Competing interests
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